| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.29 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |